NL
GMAB icon

NKCFO LLC’s Genmab GMAB Stock Holding History

NKCFO LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,000
Closed -$98K – 132
2021
Q1 		$98K Hold
3,000
– – 0.04% 111
2020
Q4 		$122K Hold
3,000
– – 0.05% 82
2020
Q3 		$110K Hold
3,000
– – 0.05% 80
2020
Q2 		$102K Hold
3,000
– – 0.07% 57
2020
Q1 		$64K Buy
+3,000
New +$66.9K 0.06% 66

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NKCFO LLC's GMAB Position: Q2 2021 in Review

NKCFO LLC sold out of Genmab (GMAB) in Q2 2021, closing a stake of 3,000 shares — an estimated $98K sold.

NKCFO LLC first reported a position in GMAB in Q1 2020 and held it in 5 quarters. The position peaked at $122K in Q4 2020. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

  • NKCFO LLC reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
  • NKCFO LLC sold 3,000 Genmab shares in Q2 2021, an estimated $98K.
  • NKCFO LLC first reported a position in Genmab in Q1 2020 and held it in 5 quarters.
  • NKCFO LLC's Genmab position peaked at $122K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on NKCFO LLC's 13F filing for Q2 2021, filed 22 Jul 2021.